ENLV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors...

Stats
Today's Volume	107 954
Average Volume	171 482
Market Cap	24.54M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $-0.250 ) 2024-06-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.900
ATR14	$0.0150 (1.13%)

Insider Trading

Date	Person	Action	Amount	type
2015-10-09	Murray Michael Anthony	Sell	56 390	Common Stock
2008-01-02	Weatherson Harvey D	Buy	12 000	Option to purchase Common Stock
2008-01-02	Raney Dennis R	Buy	12 000	Option to purchase Common Stock

INSIDER POWER
0.00
Last 3 transactions
Buy: 24 000 \| Sell: 56 390

Volume Correlation

Long: -0.19 (neutral)

Short: 0.06 (neutral)

Signal:(55.732) Neutral

Enlivex Therapeutics Ltd Correlation

10 Most Positive Correlations
MNPR	0.963
SBNY	0.956
SLN	0.945
ATNF	0.945
WKHS	0.944
ISTR	0.943
AROW	0.942
SGMO	0.941
DAWN	0.94
PETS	0.938

10 Most Negative Correlations
NVCN	-0.964
BRIVU	-0.947
MSDA	-0.943
TIOAU	-0.941
VLAT	-0.94
ENER	-0.939
TIOA	-0.938
MMAC	-0.931
BRIV	-0.931
PT	-0.929

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Enlivex Therapeutics Ltd Correlation - Currency/Commodity

-0.90
( strong negative )

-0.77
( moderate negative )

0.00
( neutral )

-0.88
( strong negative )

0.80
( moderate )

0.78
( moderate )

Enlivex Therapeutics Ltd Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-835 000 (0.00 %)
EPS:	$-1.560

Q4	2023
Revenue:	$0
Gross Profit:	$-200 000 (0.00 %)
EPS:	$-0.490

Q3	2023
Revenue:	$0
Gross Profit:	$-214 000 (0.00 %)
EPS:	$-0.320

Q2	2023
Revenue:	$0
Gross Profit:	$-212 000 (0.00 %)
EPS:	$-0.370

Financial Reports:

No articles found.

Enlivex Therapeutics Ltd